HK inno.N Corporation
195940 · KOSDAQ · South Korea
Public Market Listing
195940KOSDAQ
Live quotes, historical charts, and market capitalization for HK inno.N Corporation are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
4Total Assets
0Approved
3Phase 3 / Filed
1Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
Amlodipine/valsartan/atorvastatin (CJ-30061)No recent activity | Phase 3 | Angiotensin II receptor / Calcium channel / HMG-CoA reductaseSmall molecule | Atherosclerotic Cardiovascular Disease |
Amlodipine/valsartan/rosuvastatin (CJ-30060)No recent activity | Phase 3 | Angiotensin II receptor / Calcium channel / HMG-CoA reductaseSmall molecule | Hypertension |
AST-120(Kremezin) | Phase 3 | Oral spherical carbon adsorbentSmall molecule | Chronic Kidney Disease |
| Phase 2 | JAK1Small molecule | Atopic Dermatitis |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
Annual history (1 year)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-FY | $748M | — | — | — | report ↗ |